THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE.

Department of Health and Human Services

Award: Department of Health and Human ServicesNAICS n/aSAM# 75A50119C00055

Posted 2026-07-19 · Response deadline 2027-09-30 · Set-aside: None

Recipient: ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE) | $147062009.0

View official SAM.gov notice →

← All opportunities